Actavis
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Actavis sits in the top decile of US sponsors by registered trial count (#282 of 15,742 sponsors by registered trial count).
Actavis: 79 sponsored US clinical trials, none currently recruiting.
Actavis sponsors 79 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 79 completed. 27 of these trials are in Phase 3-4 (later-stage) and 51 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 13 trials.
Top-decile sponsor footprint
Actavis ranks in the top decile of sponsors by registered trial count (#282 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
79 of 79 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
79 total, page 1 of 2
A Clinical Endpoint Bioequivalence Study of "Oxymetazoline Hydrochloride Cream"
NCT03954444
Therapeutic Equivalence of Fluticasone Propionate Pressurized Metered Dose Inhaler, 110 mcg, to Flovent® HFA 110 mcg
NCT03879837
Therapeutic Equivalence of Two Formulations of Fluticasone Propionate and Salmeterol Inhalation Powder in Subjects With Asthma
NCT03756883
Clinical Endpoint Study of Nepafenac 0.3% Opthalmic Suspension
NCT03499873
Clinical Endpoint Study of Ivermectin 0.5% Lotion
NCT03301649
Randomized, Placebo-Controlled, Multidose, Study Comparing Generic Budesonide/Formoterol Fumarate Dihydrate to Symbicort® in Asthmatic Participants
NCT02495168
An Equivalence Study of Generic Ingenol Mebutate Gel 0.015% and Picato Gel 0.015% in Subjects With Actinic Keratosis
NCT03200912
A Study to Evaluate Safety and Equivalence of Generic Azelaic Acid Foam and Finacea® Foam in Participants With Rosacea
NCT03287791
Clinical Endpoint Study of Ivermectin 1% Cream
NCT02840461
Study to Evaluate Equivalence of Estradiol Vaginal Cream 0.01% to Estrace® Cream 0.01% in Atrophic Vaginitis
NCT03294538
Study Comparing Rifaximin With Xifaxan 200 mg in Traveler's Diarrhea
NCT02498418
Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment of Acne Vulgaris
NCT02651220
A Study of Hyaluronate Injectable Viscosupplement for Treatment of Osteoarthritis of the Knee
NCT02495857
Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris
NCT02616614
Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension to Azopt® 1% Ophthalmic Suspension In the Treatment of Chronic Open Angle Glaucoma or Ocular Hypertension in Both Eyes
NCT02512042
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis
NCT02616601
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
NCT02654769
Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis
NCT02791308
Randomized, Double-blind, Multiple-site, Placebo-controlled, Parallel-design Study in Patients With Moderate to Severe Facial Erythema Associated With Rosacea
NCT02289352
A Study To Evaluate The Safety And Therapeutic Equivalence of Tazarotene Foam 0.1% in Subjects With Acne Vulgaris
NCT02267746
Safety and Efficacy of Generic Diclofenac Epolamine Acute Pain Due to Minor Ankle Sprain
NCT02324270
A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and Both Active Treatments to a Placebo Control in the Treatment of Bacterial Vaginosis in Non-pregnant Women
NCT02210689
A Study to Evaluate the Safety and Efficacy Imiquimod Cream, 2.5% in Participants With Actinic Keratoses
NCT02120898
A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial Rosacea
NCT02120924
A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic Keratosis
NCT01962987
Clinical Equivalence Study of Mometasone Nasal Spray
NCT01850823
Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic Keratosis
NCT00948428
Single Dose Two-Way Crossover Fed Bioequivalence Study of Nabumetone 750 mg Tablets in Healthy Volunteers
NCT00864604
Single Dose Two-Way Crossover Fasted Bioequivalence Study of Nabumetone 750 mg Tablets in Healthy Volunteers
NCT00864968
A Relative Bioavailability Study of Oxycodone 5 mg / Ibuprofen 400 mg Tablets Under Non-fasting Conditions
NCT00864357
A Relative Bioavailability Study of Oxycodone 5 mg / Ibuprofen 400 mg Tablets Under Fasting Conditions
NCT00864526
A Relative Bioavailability Study of Cetirizine HCl 10 mg Tablets Under Fasting Conditions
NCT00864279
Comparison of Two KADIAN 10 mg Capsules to a KADIAN 20 mg Capsule Under Fasted Conditions
NCT00759902
Comparison of Two KADIAN 10 mg Capsules to a KADIAN 20 mg Capsule Under Fed Conditions
NCT00759915
A Relative Bioavailability Study of Cetirizine HCl 10 mg Tablets Under Non-fasting Conditions
NCT00863902
A Relative Bioavailability Study of 2 mg Alprazolam OD Tablets Under Non-Fasting Conditions
NCT01188057
A Relative Bioavailability Study of 2 mg Alprazolam OD Tablets Under Fasting Conditions
NCT01188031
Comparison of KADIAN 100 mg When Dosed With Alcohol Under Fasting and Fed Conditions Compared to Water
NCT00768183
A Relative Bioavailability Study of Bupropion Sustained Release 150 mg Tablets Under Fasting Conditions
NCT00865111
Pivotal Bioequivalence Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult Subjects
NCT00864500
The Dose-response "Pilot" Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult Subjects
NCT00864240
A Relative Bioavailability Study of Alprazolam 3 mg Extended Release Tablets Under Non-fasting Conditions
NCT00865657
A Relative Bioavailability Study of Alprazolam 3 mg ER Tablets Under Fasting Conditions
NCT00865761
A Relative Bioavailability Study of 60 mg Nifedipine Extended Release Tablets Under Fasting Conditions
NCT00865891
A Relative Bioavailability Study of Propranolol HCl 160 mg Tablets Under Non-fasting Conditions
NCT00864747
A Relative Bioavailability Study of 60 mg Nifedipine ER Tablets Under Non-fasting Conditions
NCT00864617
A Relative Bioavailability Study of Propranolol Hydrochloride 160 mg Tablets Under Fasting Conditions
NCT00865215
A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fasting Conditions
NCT00864448
A Relative Bioavailability Study of Ramipril 10 mg Capsules Administered Orally as a Sprinkle on Applesauce
NCT00863915
Comparison of One Morphine Sulfate Sustained-Release 200mg Capsule With Two 100 mg KADIAN Capsules Under Fasting Conditions
NCT00759759
How the Actavis early-phase archive is shaped
79 indexed studies, none listed as recruiting (0% open); 79 completed (100%).
Phase mix: 27 late (III/IV) vs 51 early (I/II) (early-phase heavy).
Top condition: Healthy (13 trials), 7 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Actavis: archived-pipeline peers nationwide
Peers matched on 79 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Actavis sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 79 archived trials
- BioMarin Pharmaceutical · 80 trials · 16% recruiting
- Children's Healthcare of Atlanta · 80 trials · 3% recruiting
- RAND · 78 trials · 8% recruiting
- EMD Serono Research & Development Institute · 81 trials · 11% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Actavis page
79 registered trials is a research-attention snapshot, not an endorsement of Actavis or any single study.
- None of Actavis's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Healthy is the condition Actavis studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Actavis pipeline card: 79 registered trials from official public datasets.Report a data error.